
Immunization, Vaccines and Biologicals - World Health Organization …
2010年6月30日 · Currently there are three WHO pre-qualified oral cholera vaccines (OCV): Dukoral®, Shanchol™, and Euvichol®. All three vaccines require two doses for full protection. Dukoral® is administered with a buffer solution that, for adults, requires 150 ml of clean water. Dukoral can be given to all individuals over the age of 2 years.
Clinical Review of Shanchol™ (a WHO pre-qualified oral cholera …
Shanchol™ is a ready-to-use killed bivalent (O1 and O139) whole-cell oral cholera vaccine administered as 2 doses 14 days apart in individuals aged 1 year and above. There is no need for buffer or water for its administration. It is currently licensed in India and 17 other countries in Asia, Africa and Latin America.
Shanchol and Euvichol are two examples of killed oral vaccines that have the same composition, and are relatively less expensive. Both are prequalified and are available through the WHO global stockpile.
Immunogenicity and waning immunity from the oral cholera …
2022年1月5日 · We found that Shanchol ™ was immunogenic in our study population and that vibriocidal antibodies may not be a good marker for long-term immunity. The observed rise in titres after 36 months suggests natural exposure, and this may be a critical time window opening for natural transmission in an endemic areas.
口服霍乱灭活疫苗Shanchol的相关研究 - 国际生物制品学杂志
市售霍乱疫苗Shanchol为口服双价全细胞灭活疫苗,具有良好的免疫原性和安全性,现已用于防控霍乱的大规模接种运动。 此文就Shanchol疫苗的免疫原性和应用现状、影响疫苗接种效果的因素以及疫苗在特殊人群中的安全性等相关研究进行综述。 引用本文: 周祖木, 陈敏. 口服霍乱灭活疫苗Shanchol的相关研究 [J] . 国际生物制品学杂志, 2019, 42 (2) : 88-92. DOI: 10.3760/cma.j.issn.1673-4211.2019.02.009. 版权归中华医学会所有。 未经授权,不得转载、 …
The oral cholera vaccine Shanchol™ when stored at elevated
2016年3月18日 · Background: The oral cholera vaccine (OCV), Shanchol™ has shown protective efficacy lasting up to 5 years, however, requirement for a cold chain limits its use in resource poor settings. The study was conducted to determine the safety and immunogenicity of Shanchol in adult participants in Bangladesh when stored at elevated temperatures.
Trials of the killed oral cholera vaccine (Shanchol) in India and ...
2020年2月29日 · Bangladesh and India have conducted several sequential studies of Oral Cholera Vaccine (OCV) to ascertain its safety, efficacy, effectiveness, field feasibility and acceptance in high-risk urban populations.
NEJM:单剂量口服霍乱疫苗能有效预防霍乱 - 梅斯医学 ...
研究者进行了一项研究,探究单剂量口服灭活霍乱疫苗Shanchol的有效性,当前霍乱高发地区接种双剂量的该疫苗。 孟加拉国打卡的≥1岁的非妊娠居民随机分为单剂量口服霍乱疫苗或安慰剂。 主要结果为使用疫苗后7-180天的疫苗保护效果,以培养结果作为金标准。 次要结果包括使用疫苗7-180天后培养证实霍乱感染患者的重度脱水的保护作用,以及使用疫苗后7-90天和9. 目前单剂量口服灭活霍乱疫苗已通过WHO资格预审。 研究者进行了一项研究,探究单剂量口服灭活霍乱疫 …
ORAL CHOLERA VACCINE O1 and O139 | MSF Medical Guidelines
Shanchol® vaccines used in controlled temperature chain (CTC) can be stored at temperatures of up to 40 °C for 14 days maximum. All vaccines removed from the cold chain and not used within 14 days or exposed to temperatures > 40 °C must be discarded.
Shanchol Oral Vaccine - 1mg
2025年2月10日 · Shanchol Oral Vaccine helps prevent cholera. It can be given to anyone above the age of 1 year orally. Two doses are given at an interval of at least two weeks. The protective effect begins within 7-10 days of completion of the vaccination schedule. Cholera vaccine is usually given orally (by mouth) as a single dose.
- 某些结果已被删除